Indication
Treatment Resistant Bipolar Depression
3 registered trials testing Ketamine for this indication, 1 recruiting now.
Sponsors register this under 2 different names, all collected here: Treatment Resistant Bipolar Depression · Treatment-resistant Bipolar Depression
3
Registered trials
1
Recruiting
0
In Phase 3
Stay told
When a new trial opens
Trials
All 3 trials for Treatment Resistant Bipolar Depression
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)NCT07569198 · Joshua Rosenblat | Recruiting | Phase 2 | ketamine | 1 |
| Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNCT07644767 · Neurocentrx Pharma Pty Ltd | Not yet recruiting | Phase 2 | ketamine | — |
| FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar DepressionNCT06620042 · Brian Barnett | Completed | Phase 2 | ketamine | 2 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.